Sanofi-Aventis Pays $190M To Settle Drug Price Case

Law360 (September 10, 2007, 12:00 AM EDT) -- French drug giant Sanofi-Aventis will hand over more than $190 million to settle claims by the U.S. Department of Justice and various states that its predecessor defrauded Medicare by inflating the reported average wholesale price of a cancer drug.

The settlement, announced Monday, resolves claims against Aventis Pharmaceuticals Inc. in the massive antitrust class action consolidated in 2003 in the U.S. District Court for the District of Massachusetts alleging a bunch of big-name drug makers bilked the U.S. government and consumers by artificially boosting the prices of various prescription medications.

As part of the settlement, federal prosecutors will file a stipulation...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS